Royer, Michael F.
Hauser, Michelle E.
Zamora, Astrid N.
Campero, Maria Ines
Garcia, Dulce
Gabaray, Martha
Sheats, Jylana L.
King, Abby C.
Funding for this research was provided by:
National Institutes of Health (5T32HL007034-39)
National Heart, Lung, and Blood Institute (5R01HL116448)
National Center for Mobility Data Integration and Insight (1U54EB020405)
Article History
Received: 26 April 2024
Accepted: 9 July 2024
First Online: 23 July 2024
Declarations
:
: The Stanford University School of Medicine Institutional Review Board approved the study protocol for the COMPASS Trial. All Study materials, including informed consent and recruitment, intervention, and assessment forms, were produced in English and translated into Spanish by certified translators. Participants provided written consent to join the study upon reviewing the informed consent form with a bilingual staff member. The trial was registered at ClinicalTrials.gov (NCT02111213).
: Not applicable.
: The authors declare no competing interests.